EMT plays a critical role in tumor invasiveness and metastasis, and pioglitazone enhanced E-cadherin expression while suppressing mesenchymal markers, thereby inhibiting EMT and reducing the metastatic potential of NSCLC [78]. Here, CDH1 is linked to non-small cell lung carcinoma.